Isomab

Professor Bill Sessa, previously Chief Scientific Officer of Internal Medicine at Pfizer, has been appointed Chair of Isomab's Scientific Advisory Board. The appointment was announced via PR Newswire. It signals Isomab's effort to strengthen its scientific leadership as it advances its development programs, bringing senior pharmaceutical industry experience to the company's advisory structure.